期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 291 (5)
Objectives Liver-derived apolipoprotein B-100 (ApoB100) is an autoantigen that is recognized by atherogenic CD4(+) T cells in cardiovascular disease (......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 291 (2)
Background and objectives The absence of obstructive coronary artery disease (CAD) in patients with angina is common, but its prognosis is debated. We......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 292 (6)
Background Dyspnea is common after COVID-19. Though the underlying mechanisms are largely unknown, lung perfusion abnormalities could contribute to li......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 292 (1)
Lung cancer causes more deaths than breast, cervical, and colorectal cancer combined. Nevertheless, population-based lung cancer screening is still no......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 292 (3)
DNA methylation is an epigenetic modification that has consistently been shown to be linked with a variety of human traits and diseases. Because DNA m......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 292 (1)
The blood-brain barrier (BBB) is essential for creating and maintaining tissue homeostasis in the central nervous system (CNS), which is key for prope......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 291 (3)
Background Recent studies demonstrate that prothrombotic antiphospholipid antibodies (aPL) are overrepresented in patients with myocardial infarction ......
期刊: JOURNAL OF INTERNAL MEDICINE, 2022; 291 (5)
Background The cardiovascular benefit from n-3 polyunsaturated fatty acids (PUFAs) after acute myocardial infarction (AMI) is controversial, and the i......